N-(bromoacetyl)-3,3-dinitroazetidine June 17, 2017 N-(bromoacetyl)-3,3-dinitroazetidine Trade Name Orphan Indication Small cell lung cancer USA Market Approval USA USA Designation Date 2017-06-15 00:00:00 Sponsor EpicentRx, Inc.;4445 Eastgate Mall, Suite 200;San Diego, California, 92121